Ultrasound-guided corticosteroid injection therapy for juvenile idiopathic arthritis: 12-year care experience.
Pediatr Radiol., Dec;42(12):1481-9 (2012)
Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis.
J. Rheumatol., Aug;39(8):1687-97 (2012)
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.
Arthritis Care Res (Hoboken)., Aug;64(8):1175-85 (2012)
Inactive disease and remission in childhood-onset systemic lupus erythematosus.
Arthritis Care Res (Hoboken)., May;64(5):683-93 (2012)
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
Arthritis Rheum., Jun;64(6):2012-21 (2012)
Use of atorvastatin in systemic lupus erythematosus in children and adolescents.
Arthritis Rheum., Jan;64(1):285-96 (2012)
Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus.
Arthritis Care Res (Hoboken)., Sep;63(9):1213-23 (2011)
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
Arthritis Rheum., Feb;63(2):545-55 (2011)
Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.
Lupus., Oct;19(11):1315-25 (2010)
Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus.
Arthritis Care Res (Hoboken)., Jul;62(7):950-9 (2010)
Toward the development of criteria for global flares in juvenile systemic lupus erythematosus.
Arthritis Care Res (Hoboken)., Jun;62(6):811-20 (2010)
Prospective validation of the provisional criteria for the evaluation of response to therapy in childhood-onset systemic lupus erythematosus.
Arthritis Care Res (Hoboken)., Mar;62(3):335-44 (2010)
Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists.
J. Rheumatol., Jan;37(1):175-81 (2010)
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.
J. Rheumatol., Dec;36(12):2819-29 (2009)
Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus.
J. Rheumatol., Jul;36(7):1536-45 (2009)
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort.
Arthritis Rheum., May;60(5):1496-507 (2009)
Adherence to medications in systemic lupus erythematosus.
J Clin Rheumatol., Aug;14(4):195-201 (2008)
Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting.
Arthritis Rheum., Aug;57(6):1000-6 (2007)
Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European America
Am. J. Hum. Genet., Jun;80(6):1037-54 (2007)
Current medication choices in juvenile rheumatoid arthritis II--update of a survey performed in 1993.
J Clin Rheumatol., Oct;7(5):295-300 (2001)